Export 5 results:
Author Title [ Type(Desc)] Year
Filters: Author is Doody, Rachelle S  [Clear All Filters]
Journal Article
J. Jia, Wei, C., Jia, L., Tang, Y., Liang, J., Zhou, A., Li, F., Shi, L., and Doody, R. S., Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial., J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R., Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease., N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
K. Li, Chan, W., Doody, R. S., Quinn, J., and Luo, S., Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data., J Alzheimers Dis, vol. 58, no. 2, pp. 361-371, 2017.
S. Nave, Doody, R. S., Boada, M., Grimmer, T., Savola, J. - M., Delmar, P., Pauly-Evers, M., Nikolcheva, T., Czech, C., Borroni, E., Ricci, B., Dukart, J., Mannino, M., Carey, T., Moran, E., Gilaberte, I., Muelhardt, N. Milani, Gerlach, I., Santarelli, L., Ostrowitzki, S., and Fontoura, P., Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)., J Alzheimers Dis, vol. 58, no. 4, pp. 1217-1228, 2017.
S. Salmerón, Huedo, I., López-Utiel, M., Soler-Moratalla, I., Flores-Ruano, T., Fernández-Sánchez, M., Noguerón, A., Doody, R. S., and Abizanda, P., Validation of the Spanish version of the Baylor Profound Mental Status Examination., J Alzheimers Dis, vol. 49, no. 1, pp. 73-8, 2016.